MedTrace Logo

Clinical Trial of Donepezil Between the Naive Group and the Switching Group

NCT01023425 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2016-01-06

No results posted yet for this study

Summary

To compare the clinical efficacy of donepezil between the naive group and the switching group.

Conditions

Interventions

DRUG

donepezil

from 5mg to 10mg, once a day, 12 months

Sponsors & Collaborators

  • Eisai Korea Inc.

    collaborator INDUSTRY

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Doh Kwan Kim, PhD, M.D. · Samsung Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01023425 on ClinicalTrials.gov